The role of inflammatory cells in angiogenesis in multiple myeloma

Advances in Experimental Medicine and Biology

Volumn 816, Issue , 2014, Pages 361-376

  Ribatti, Domenico ^a,b   Vacca, Angelo ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Angiogenesis; Inflammation; Macrophages; Mast cells; Multiple myeloma

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; CLODRONIC ACID; COLONY STIMULATING FACTOR 1; CROMOGLYCATE DISODIUM; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 2ALPHA; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LENALIDOMIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; NERVE GROWTH FACTOR; NOTCH RECEPTOR; PENTRAXIN 3; PLACENTAL GROWTH FACTOR; POMALIDOMIDE; RANTES; SOMATOMEDIN B; STROMAL CELL DERIVED FACTOR 1ALPHA; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 27; SYNDECAN 1;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER GROWTH; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INFLAMMATORY CELL; INNATE IMMUNITY; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAST CELL; MONOCYTE; MULTIPLE MYELOMA; NONHUMAN; PRIORITY JOURNAL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; CARCINOGENESIS; CELL COMPONENT; IMMUNOREGULATION; NEOVASCULARIZATION (PATHOLOGY); PROTEIN FUNCTION;

EID: 84959237996     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-3-348-837-8_14     Document Type: Article

References (119)

1. Abdel-Majid RM, Marshall JS (2004) Prostaglandin E2 induces degranulation independent production of vascular endothelial growth factor by human mast cells. J Immunol 172:1227-1236
2. Aharinejad S, Abraham D, Paulus P et al (2002) Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Res 62:5317-5324
3. Aharinejad S, Paulus P, Sioud M et al (2004) Colony-stimulating factor-1 blockade by antisense oligonucleotide and small interfering RNAs suppresses growth of human mammary tumor xenograft in mice. Cancer Res 64:5378-5384
4. Andreu P, Johansson M, Affar a NI et al (2010) FcR gamma activation regulates inflammationassociated squamous carcinogenesis. Cancer Cell 17:121-134
5. Angiolillo AL, Sgadari C, Taub DD et al (1995) Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 182:155-162
6. Aoki M, Pawankar R, Niimi Y et al (2003) Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES. Int Arch Allergy Immunol 130:216-223
7. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357:539-545
8. Balkwill F, Charles KA, Mantovani A (2005) Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7:211-217
9. Basile A, Moschetta M, Ditonno P e t al (2013) Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients. J Pathol 229:87-98
10. Benitez-Bribiesca L, Wong A, Utrera D et al (2001) Th e role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem 49:1061-1062
11. Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196:254-265
12. Blair RJ, Meng H, Marchese MJ et al (1997) Human mast cells stimulate vascular tube formation: tryptase is a novel potent angiogenic factor. J Clin Invest 99:2691-2700
13. Boesiger J, Tsai M, Maurer M et al (1998) Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of fc epsilon receptor I expression. J Exp Med 188:1135-1145
14. Bowrey PF, King J, Magarey C et al (2000) Histamine, mast cells an d tumour cell proliferation in breast cancer: does preoperative cimetidine administration have an effect? Br J Cancer 82:167-170
15. Cocco C, Morandi F, Airoldi J (2011) Interleukin-27 and interleukin-23 modulate human plasma cell functions. J Leukoc Biol 89:729-734
16. Colombo MP, Trinchieri G (2002) Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13:155-168
17. Coussens LM, Raymond WW, Bergers G et al (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13:1382-1397
18. Coussens LM, Tinkle CL, Hana han D et al (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481-490
19. Denhardt DT, Noda M, O'Regan AW et al (2001) Osteopontin as a means to co pe with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest 107:1055-1061
20. De Palma M, Venneri MA, Galli R et al (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8: 211-226
21. Detmar M, Brown LF, Schö n MP et al (1998) Increased microvascular density and enhanced leukocyte rolling and adhesionin the skin of VEGF transgenic mice. J Invest Dermatol 111:1-6
22. Detoraki A, Staiano RI, Granata F et al (2009) Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects. J Allergy Clin Immunol 123:1142-1149
23. de Visser KE, Korets LV, Coussens LM (2005) De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7:411-423
24. Dias S, Boyd R, Balkwill F (1998) IL-12 regulates VEGF and MMPs in a murine breast cancer model. Int J Cancer 78:361-365
25. Dineen SP, Lynn KD, Holloway SE et al (2008) Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into or thotopic pancreatic tumors in mice. Cancer Res 68:4340-4346
26. Di Raimondo F, Azzaro MP, Palombo G et al (2000) Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Haematologica 85:800-805
27. Dvorak AM, Mihm MC Jr, Osage JE et al (1980) Melanoma. An ultrastructural study of the host inflammatory and vascular responses. J Invest Dermatol 75:388-393
28. Egami K, Murohara T, Shimada T et al (2003) Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112:67-75
29. Elpek GO, Gelen T, Aksoy NH et al (2001) The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the esophagus. J Clin Pathol 54:940-944
30. Fukushima N, Satoh T, Sano M et al (2001) Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma. Leuk Lymphoma 42:709-720
31. Giraudo E, Inoue M, Hanahan D (2004) An aminobisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Invest 114:623-633
32. Glowacki J, Mulliken JB (1982) Mast cells in hemangiomas and vascular malformations. Pediatrics 70:48-51
33. Gounaris E, Erdman SE, Restaino C et al (2007) Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci USA 104:19977-19982
34. Graham R, Graham J (1996) Mast cells and cancer of the cervix. Surg Gynecol Obstet 123:3-9
35. Grimbaldesnton MA, Nakae S, Kalesnikoff K et al (2007) Mast cell-derived interleukin 10 l imits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 38:1095-1104
36. Gruber BL, Marchese MJ, Kew R (1995) Angiogenic factors stimulate mast cell migration. Blood 86:2488-2493
37. Grü tzkau A, Krüger-Krasagakes S, Baumeister H et al (1998) Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast ce lls: implications for the biological significance of VEGF206. Mol Biol Cell 9:875-884
38. Guiducci L, Vicari AP, Sangaletti S et al (2005) Redirecting in vivo elicited tumor infiltrating macrophages and den dritic cells towards tumor rejection. Cancer Res 65:3437-3446
39. Hanada T, Nakagawa M, Emoto A et al (2000) Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 7:263-269
40. Hartveit F 1981i Mast cells and metachromasia in human breast cancer: their occurrence, significance and consequence: a preliminary report J Pathol 134: 7-11
41. Hideshima T, Mitsiades C, Tonon G et al (2007) Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 7:585-598
42. Huang B, Lei Z, Zhang GM et al (2008) SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 112:1269-1279
43. Imada A, Shijubo N, Koijma H et al (2000) Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma. Eur Resp J 15:1087-1093
44. Imtiyaz HZ, Williams EP, Hickey MM et al (2010) Hypoxia-inducible fa ctor 2 alpha regulates macrophage function in mouse models of acute and tumor inflammation. J Clin Invest 120:2699-2714
45. Jenkins DC, Charles IG, Thomsen LL et al (1995) Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92:4392-4396
46. Kanbe N, Kurosawa M, Nagata H et al (2000) Production of fibrogenic cytokines by cord bloodderived cultured human mast cells. J Allergy Clin Immunol 106:S85-S90
47. Klimp AH, Hollema H, Kempinga C et al (2001) Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res 61:7 305-7309
48. Koide N, Nishio A, Sato T et al (2004) Significance of macrophage chemoattractant protein-1expression and macrophage infiltration in squamous cell carcinoma of the esophagus. Am J Gastroenterol 99:1667-1674
49. Kumar S, Witzig TE, Timm M et al (2004) Bone marrow angiogenic ability and e xpression of angiogenic cytokines in myeloma: evidence favouring loss of marrow angiogenesis inhibitory activity with disease progression. Blood 104:1159-1165
50. Lachter J, Stein M, Lichting C et al (1995) Mast cells in colorectal neoplasias and premalignant disorders. Dis Colon Rectum 38:290-293
51. Leali D, Dell'Era P, Stabile H et al (2003) Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. J Immunol 171:1085-1093
52. Leek RD, Lewis CE, Whitehouse R et al (1996) Association of macrophage infiltration with breast carcinoma. Cancer Res 56:4625-4629
53. Leek RD, Landers RJ, Harris AL et al (1999) Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 79:991-995
54. Lewis CE, Lee k R, Harris A et al (1995) Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 57:747-751
55. Lin EY, Nguyen AV, Russel RG et al (2001) Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 193:727-740
56. Lin EY, Li JF, Gnatovskiy L et al (2006) Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66:11238-11246
57. Lin EY, Li JF, Bricard G et al (2007) Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages. Mol Oncol 1:288-302
58. Lissbrant IF, Stattin P, Wikstrom P et al (2000) Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol 17:445-451
59. Makitie T, Summanen P, Takkanen A et al (2001) Tumor-infiltrating macrophages (CD68+ cells) and prognosis in malignant uveal melanoma. Invest Ophtalmol Vis Sci 42:1414-1421
60. Ma ngieri D Nico B Benagiano V et al 2008 Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a downregulation in the expression of endogenous endostat in J Cell Mol Med 12: 1023-1028
61. Manthey CL, Johnson DL, Illig CR et al (2009) JNI-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid t umors, bone metastases, and acute myeloid leukemia. Mol Cancer Ther 8:3151-3161
62. Mantovani A, Sozzani S, Locati M (2002) Macrophage polarization: tumor associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549-555
63. Mazzieri R, Pucci F, Moi D et al (2008) Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebound s of proangiogenic myeloid cells. Cancer Cell 14:299-311
64. Metcalfe DD, Baram D, Mekori YA (1997) Mast cells. Physiol Rev 77:1033-1079
65. Molica S, Vacca A, Crivellato E et al (2003) Tryptase-positive mast cells predict clinical outcome of patients with B-cell chronic lymphocytic leukemia. Eur J Haematol 71:137-139
66. Moller A, Lippert U, Lessmann D et al (1993) Human mast cells produce IL-8. J Immunol 151:3261-3266
67. Movahedi K, Laoui D, Gysemans C et al (2010) Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6 C(high) monocytes. Cancer Res 70:5728-5739
68. Nakao S, Kuwano T, Tsutsumi-Miyahara C et al (2005) Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1beta-induced neovascularization and tumor growth. J Clin Inves 115:2979-2991
69. Nakayama T, Yao L, Tosato G (2004) Mast cell derived angiopoietin-1 plays a role in the growth of plasma cell tumors. J Clin Invest 114:1317-1325
70. Naldini A, Carraro F (2005) Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 4:3-8
71. Naldini A, Leali D, Pucci A et al (2006) Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes. J Immunol 177:4267-4270
72. Nico B, Mangieri D, Crivellato E et al (2008) Mast cells contribute to vasculogenic mimicry in multiple myeloma. Stem Cells Dev 17:19-22
73. Nishie A, Ono M, Shono T et al (1999) Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. Clin Cancer Res 5:1107-1113
74. Nilsson G, Forsberg-Nilsson K, Xiang Z et al (1997) Human mast cells express functional TrkA and are a source of nerve growth factor. Eur J Immunol 27:2295-2301
75. Norrby K, Jakobsson A, Sö rbo J (1986) Mast cell-mediated angiogenesis: a novel experimental model using the rat mesentery. Virchows Arch B Cell Pathol Mol Pathol 52:195-206
76. Norrby K, Jakobsson A, Sörbo J (1989) Mast-cell secretion and angiogenesis, a quantitative study in rats and mice. Virchows Arch B Cell Pathol Mol Pathol 57:251-256
77. Ohno S, Ohno Y, Suzuki N et al (2004) Correlat ion of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. Anticancer Res 24:3335-3342
78. Pittoni P, Tripodo C, Piconese S et al (2011) Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers. Cancer Res 71:5987-5997
79. Pober JS, Sessa WC (2007) Evolving functions of endothelial cells in inflammation. Nat Rev Immunol 7:803-815
80. Pucci F, Venneri MA, Biziato D et al (2009) A distinguishing gene signature shared by tumorinfiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 114:901-914
81. Qian BZ, Pollard JM (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141:39-51
82. Qu Z, Liebler JM, Powers MR et al (1995) Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 147:564-573
83. Qu Z, Huang X, Ahmadi P et al (1998a ) Synthesis of basic fibroblast growth factor by murine mast cells. Regulation by transforming growth factor beta, tumor necrosis factor alpha, and stem cell factor. Int Arch Al lergy Immunol 115:47-54
84. Qu Z, Kayton RJ, Ahmadi P et al (1998b ) Ultrastructural immunolocalization of basic fibroblast growth factor in mast cells secretory granules. Morphological evidence for bfgf release through degranulation. J Histochem Cytochem 46:1119-1128
85. Reed JA, McNutt NS, Bogdany JK et al (1996) Expression of the mast cell growth factor interleukin-3 in the melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression. J Cutan Pathol 23:495-505
86. Ribatti D, Roncali L, Nico B et al (1987) Effects of exogenous heparin on the vasculogenesis of the chorioallantoic membrane. Acta Anat 130:257-263
87. Ribatti D, Nico B, Vacca A et al (1998) Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas? Br J Cancer 77:1900-1906
88. Ribatti D, Vacca A, Nico B et al (1999) Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer 79:451-455
89. Ribatti D, Vacca A, Marzullo A et al (2000) Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer 85:17 1-175
90. Ribatti D, Crivellato E, Candussio L et al (2001) Mast cells and their secretory granules are angiogenic in the chick embryo chorioallantoic membrane. Clin Exp Allergy 31:602-608
91. R ibatti D, Polimero G, Vacca A et al (2002) Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia 16:1680-1684
92. Ribatti D, Vacca A, R ia R et al (2003a ) Neovascularization, expression of basic fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer 39:66 6-675
93. Ribatti D, Molica S, Vacca A et al (2003b ) Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia 17:1428-1430
94. Ribatti D, Vacca A, Ria R et al (2003c ) Neovascularization, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eu r J Cancer 39:666-674
95. Ribatti D, Finato N, Crivellato E et al (2005) Neovascularization and mast cells with tryptase activity increase simultaneously with pathological progression in human endometrial cancer . Am J Obstet Gynecol 193:1961-1965
96. Ribatti D, Nico B, Vacca A (2006) Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 25:4257-4266
97. Ribatti D, Crivellato E (2009) The controversial role of mast cells in tumor growth. Int Rev Cell Mol Biol 275:89-131
98. Ribatti D, Crivellato E (2012) Mast cells, angiogenesis, and tumor growth. Biochim Biophys Acta Mol Basis Dis 1822:2-8
99. Rojas IG, Spencer ML, Martinez A et al (2005) Characterization of mast cell subpopulations in lip cancer. J Oral Pathol Med 34:268-273
100. Romagnani P, Annunziato F, Lasagni L et al (2001) Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 107:53-63
101. Sawatsubashi M, Yamada T, Fukushima N et al (2000) Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch B Cell Pathol Mol Pathol 436:243-248
102. Scavelli C, Nico B, Cirulli T et al (2008) Vasculogenic mimicry by bone marrow macrophages in patient with multiple myeloma. Oncogene 27:663-674
103. Sica A Schioppa T Mantovani A et al 2006 Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential target sof anti-cancer therapy Eur J Cancer 42: 717-727
104. Sö rbo J, Jakobbson A, Norrby K (1994) Mast cell histamine is angiogenic through receptors for histamine 1 and histamine 2. Int J Exp Pathol 75:43-50
105. Soucek L, Lawlor ER, Soto D et al (2007) Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 13:1211-1218
106. Starkey JR, Crowle PK, Taubenberger S (1988) Mast cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 42:48-52
107. Stockmann C, Doedens A, Weidemann A et al (2008) Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 456:814-818
108. Takanami I, Takeuchi K, Naruke M (2000) Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 88:2686-2692
109. Talmadge JE, Donkor M, Scholar E (2007) Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Met Rev 26:373-400
110. Theoharides TC, Conti P (2004) Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 25:235-241
111. Tomita M, Matsuzaki Y, Onitsuka T (2000) Effect of mast cells on tumor angiogenesis in lung cancer. Ann Thorac Surg 69:1686-1689
112. Tó th-Jakatics R, Jimi S, Takebayashi S et al (2000) Cutaneous malignant melanoma: correlation between neovascularization and peritumoral accumulation of mast cells overexpressing vascular endothelial growth fact or. Human Pathol 31:955-960
113. Ullrich SE, Nghiem DX, Khaskina P (2007) Suppression of an established immune response by UVA-A critical role for mast cells. Photochem Photobiol 83:1095-1100
114. Vacca A, Ribatti D (2006) Bone marrow angiogenesis in multiple myeloma. Leukemia 20:193-199
115. Vacca A, Ribatti D, Presta M et al (1999) Bone marrow neovascularization, plasma ce ll angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 93:3064-3073
116. Vacca A, Semeraro F, Merchionne F et al (2003) Endothelial cells in the bone marrow of patients with multiple myeloma. Blood 102:3340-3348
117. Walsh LJ, Trinchieri G, Waldorf HA et al (1991) Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci USA 88:4220-4224
118. Wanachantatak S (2003) Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med 23:195-199
119. Zeisberger SM, Odermatt B, Marty C et al (2006) Clodronate-liposome- mediated depletion of tumour-associated macrophages: a new high and highly effective antiangiogenic therapy approach. Br J Cancer 95:272-281